Log in to save to my catalogue

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer...

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_869072278

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy

About this item

Full title

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy

Publisher

Boston: Springer US

Journal title

Medical oncology (Northwood, London, England), 2011-06, Vol.28 (2), p.488-493

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

The efficacy and safety of generic and brand name levofolinate injectable drugs were evaluated in 42 chemotherapy-naïve patients with colorectal cancer who received the combination chemotherapy of levofolinate, 5-fluorouracil, and oxaliplatin with or without bevacizumab. The tumor response rate was similar between generic drug group and brand drug...

Alternative Titles

Full title

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_869072278

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_869072278

Other Identifiers

ISSN

1357-0560

E-ISSN

1559-131X

DOI

10.1007/s12032-010-9487-2

How to access this item